Ładowanie…
596 spółek, które pokrywamy, z czego 361 ocenionych
Każda spółka tutaj przepuszczona przez te same pięć testów wzrostu i generowania gotówki. To opisuje branżę tak, jak raportuje dziś — a nie którą z tych spółek kupić.
| VRTX | VERTEX PHARMACEUTICALS INC / MA | B+ | 133,4B USD | 526,19 USD | 30,65 | 12,6B USD | 35,0% |
| REGN | REGENERON PHARMACEUTICALS, INC. | C+ | 84,2B USD | 788,04 USD | 19,47 | 15,5B USD | 27,9% |
| MRNA | Moderna, Inc. | D- | 79,4B USD | 198,88 USD | — | 2,2B USD | -141,4% |
| LGVN | LONGEVERON INC. | F- | 79B USD | 2,81 USD | — | 1,2M USD | -1977,6% |
| ARGX | ARGENX SE | bez oceny | 59,4B USD | 959,49 USD | 49,03 | — | — |
| RVMD | Revolution Medicines, Inc. | F | 43,9B USD | 204,97 USD | — | 0,00 USD | — |
| ONC | BEONE MEDICINES LTD. | A+ | 41B USD | 360,85 USD | 64,55 | 6,1B USD | 10,7% |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | A+ | 34,2B USD | 255,96 USD | 129,93 | 3,7B USD | 19,7% |
| RPRX | Royalty Pharma plc | B+ | 32,4B USD | 58,21 USD | 30,96 | 2,5B USD | 32,1% |
| NCNA | NUCANA PLC | bez oceny | 26,6B USD | 1,28 USD | — | — | — |
| ROIV | ROIVANT SCIENCES LTD. | F- | 25,9B USD | 35,80 USD | — | 7,5M USD | -3535,0% |
| INSM | INSMED INC | C- | 25,7B USD | 117,83 USD | — | 1,1B USD | -76,9% |
| INCY | INCYTE CORPORATION | A+ | 24,8B USD | 123,89 USD | 17,50 | 5,4B USD | 26,7% |
| BNTX | BioNTech SE | D | 24,7B USD | 98,52 USD | — | 3B USD | -42,9% |
| JAZZ | Jazz Pharmaceuticals plc | A+ | 15,4B USD | 237,95 USD | 16,26 | 4,6B USD | 20,4% |
| AKTX | Akari Therapeutics, Plc | bez oceny | 15,2B USD | 9,76 USD | — | — | — |
| EXEL | Exelixis Inc | A+ | 14,4B USD | 58,16 USD | 18,29 | 2,4B USD | 35,3% |
| ASND | Ascendis Pharma A/S | D | 14B USD | 225,60 USD | — | 1,2B USD | -21,8% |
| HALO | HALOZYME THERAPEUTICS, INC. | A+ | 12,9B USD | 113,90 USD | 33,21 | 1,7B USD | 24,9% |
| BBIO | BridgeBio Pharma, Inc. | B | 12,8B USD | 65,57 USD | — | 713,1M USD | -98,5% |
| CORT | CORCEPT THERAPEUTICS INC | C | 12,6B USD | 116,10 USD | 276,43 | 830,8M USD | 6,6% |
| SMMT | Summit Therapeutics Inc. | F | 12,5B USD | 15,61 USD | — | 0,00 USD | — |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | C- | 11,9B USD | 516,56 USD | — | 1,3B USD | -25,3% |
| BMRN | BIOMARIN PHARMACEUTICAL INC | A | 11,7B USD | 60,26 USD | 162,86 | 3,4B USD | 2,1% |
| TWST | Twist Bioscience Corporation | C- | 11,5B USD | 182,83 USD | — | 431,8M USD | -31,7% |
| TECH | BIO-TECHNE Corp | B+ | 11,4B USD | 72,61 USD | 63,14 | 1,2B USD | 15,0% |
| KRYS | Krystal Biotech, Inc. | A+ | 10,2B USD | 345,82 USD | 43,34 | 440,5M USD | 54,8% |
| AXSM | AXSOME THERAPEUTICS, INC. | B- | 10,2B USD | 195,09 USD | — | 776,6M USD | -24,7% |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | D- | 9,3B USD | 65,92 USD | — | 669,5M USD | -47,8% |
| KYMR | KYMERA THERAPEUTICS, INC. | D- | 9,3B USD | 111,95 USD | — | 105M USD | -285,3% |
| PTGX | Protagonist Therapeutics, Inc | A+ | 9,2B USD | 141,86 USD | 139,08 | 282M USD | 29,4% |
| CAI | CARIS LIFE SCIENCES, INC. | A+ | 9B USD | 31,98 USD | 18,92 | 989,6M USD | 10,6% |
| CYTK | CYTOKINETICS, INCORPORATED | F | 9B USD | 64,66 USD | — | 67,7M USD | -1321,1% |
| IBRX | IMMUNITYBIO, INC. | B | 8,9B USD | 8,44 USD | — | 165,8M USD | -598,6% |
| TGTX | TG THERAPEUTICS, INC. | A+ | 8,8B USD | 57,43 USD | 20,88 | 799,5M USD | 55,2% |
| PCVX | VAXCYTE, INC. | bez oceny | 8,4B USD | 56,21 USD | — | — | — |
| PRAX | PRAXIS PRECISION MEDICINES, INC. | F | 7,8B USD | 280,78 USD | — | 0,00 USD | — |
| GPCR | Structure Therapeutics Inc. | bez oceny | 7,7B USD | 35,93 USD | — | — | — |
| SYRE | SPYRE THERAPEUTICS, INC. | F | 7,6B USD | 85,69 USD | — | 0,00 USD | — |
| IONS | Ionis Pharmaceuticals, Inc. | F- | 7,4B USD | 44,50 USD | — | 874,1M USD | -64,7% |
| ABVX | Abivax S.A. | bez oceny | 7,2B USD | 91,06 USD | — | — | — |
| IMVT | IMMUNOVANT, INC. | bez oceny | 6,9B USD | 33,30 USD | — | — | — |
| RYTM | RHYTHM PHARMACEUTICALS, INC. | C- | 6,8B USD | 98,66 USD | — | 239,9M USD | -85,6% |
| BLTE | Belite Bio, Inc | bez oceny | 6,6B USD | 167,33 USD | — | — | — |
| LGND | LIGAND PHARMACEUTICALS INCORPORATED | A+ | 6B USD | 301,52 USD | 32,04 | 290,5M USD | 67,9% |
| CGON | CG Oncology, Inc. | D- | 6B USD | 67,15 USD | — | 6,2M USD | -3602,7% |
| SRRK | SCHOLAR ROCK HOLDING CORPORATION | F | 5,9B USD | 48,63 USD | — | 0,00 USD | — |
| MIRM | Mirum Pharmaceuticals, Inc. | D- | 5,8B USD | 89,70 USD | — | 618,1M USD | -139,2% |
| COGT | Cogent Biosciences, Inc. | bez oceny | 5,6B USD | 32,31 USD | — | — | — |
| TVTX | TRAVERE THERAPEUTICS, INC. | D- | 5,6B USD | 59,44 USD | — | 591,3M USD | -7,4% |
| ORKA | Oruka Therapeutics, Inc. | bez oceny | 5,6B USD | 84,46 USD | — | — | — |
| GOSS | GOSSAMER BIO, INC. | B | 5,3B USD | 10,94 USD | — | 53,3M USD | -235,0% |
| CRSP | CRISPR THERAPEUTICS AG | F- | 5,2B USD | 54,23 USD | — | 13,4M USD | -3368,7% |
| PTCT | PTC Therapeutics, Inc. | D | 5,2B USD | 62,67 USD | — | 1B USD | -3,8% |
| ERAS | Erasca, Inc. | bez oceny | 5B USD | 14,25 USD | — | — | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | B- | 5B USD | 11,00 USD | — | 325M USD | -89,1% |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | F- | 5B USD | 88,55 USD | — | 2M USD | -9442,3% |
| MANE | Veradermics, Inc | bez oceny | 4,9B USD | 116,57 USD | — | — | — |
| DFTX | Definium Therapeutics, Inc. | bez oceny | 4,9B USD | 36,17 USD | — | — | — |
| EWTX | Edgewise Therapeutics, Inc. | bez oceny | 4,3B USD | 39,34 USD | — | — | — |
| TNGX | Tango Therapeutics, Inc. | F- | 4,2B USD | 24,92 USD | — | 53,8M USD | -229,9% |
| VKTX | Viking Therapeutics, Inc. | F | 4,1B USD | 35,56 USD | — | 0,00 USD | — |
| ABCL | AbCellera Biologics Inc. | D- | 3,9B USD | 12,70 USD | — | 66,2M USD | -248,8% |
| CELC | CELCUITY INC. | bez oceny | 3,9B USD | 79,52 USD | — | — | — |
| TLX | Telix Pharmaceuticals Limited | D- | 3,9B USD | 11,45 USD | — | 803,8M USD | -0,9% |
| RLAY | Relay Therapeutics, Inc. | C- | 3,8B USD | 17,47 USD | — | 10,4M USD | -2763,6% |
| XENE | XENON PHARMACEUTICALS INC. | F | 3,6B USD | 36,94 USD | — | 0,00 USD | — |
| ACAD | ACADIA PHARMACEUTICALS INC. | A+ | 3,6B USD | 20,68 USD | 9,27 | 1,1B USD | 33,4% |
| IDYA | IDEAYA Biosciences, Inc. | D- | 3,5B USD | 36,69 USD | — | 234,1M USD | -74,8% |
| LEGN | Legend Biotech Corp | C- | 3,5B USD | 19,11 USD | — | 1B USD | -24,6% |
| DBVT | DBV Technologies S.A. | F- | 3,4B USD | 11,56 USD | — | 5M USD | -3506,5% |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | A | 3,4B USD | 26,92 USD | 128,19 | 464M USD | 6,1% |
| TARS | TARSUS PHARMACEUTICALS, INC. | A | 3,3B USD | 75,69 USD | — | 606,3M USD | -7,7% |
| ELVN | ENLIVEN THERAPEUTICS, INC. | bez oceny | 3,3B USD | 44,75 USD | — | — | — |
| DNLI | Denali Therapeutics Inc. | F- | 3,3B USD | 20,39 USD | — | 3,6M USD | -14 191,2% |
| RCUS | Arcus Biosciences, Inc. | D- | 3,2B USD | 24,97 USD | — | 117M USD | -393,2% |
| DYN | Dyne Therapeutics, Inc. | bez oceny | 3B USD | 16,03 USD | — | — | — |
| PGEN | PRECIGEN, INC. | F- | 2,8B USD | 7,75 USD | — | 9,7M USD | -1628,5% |
| NAMS | NewAmsterdam Pharma Company N.V. | F- | 2,7B USD | 22,58 USD | — | 7,1M USD | -3644,2% |
| MBX | MBX Biosciences, Inc. | bez oceny | 2,6B USD | 53,63 USD | — | — | — |
| BEAM | Beam Therapeutics Inc. | C- | 2,5B USD | 24,27 USD | — | 156M USD | -54,7% |
| IRON | Disc Medicine, Inc. | bez oceny | 2,5B USD | 65,24 USD | — | — | — |
| CLDX | Celldex Therapeutics, Inc. | F- | 2,4B USD | 31,10 USD | — | 158K USD | -190 220,9% |
| IMNM | Immunome, Inc. | F | 2,4B USD | 21,41 USD | — | 0,00 USD | — |
| QURE | uniQure N.V. | C- | 2,4B USD | 38,23 USD | — | 18,1M USD | -1154,4% |
| HRMY | HARMONY BIOSCIENCES HOLDINGS, INC. | A+ | 2,4B USD | 41,26 USD | 13,35 | 959,9M USD | 18,9% |
| NRIX | NURIX THERAPEUTICS, INC. | F- | 2,4B USD | 23,01 USD | — | 36,8M USD | -928,4% |
| VERA | Vera Therapeutics, Inc. | bez oceny | 2,3B USD | 32,54 USD | — | — | — |
| SLS | SELLAS Life Sciences Group, Inc. | bez oceny | 2,3B USD | 11,61 USD | — | — | — |
| VRDN | Viridian Therapeutics, Inc./DE | D- | 2,3B USD | 20,47 USD | — | 71,1M USD | -544,1% |
| MLYS | MINERALYS THERAPEUTICS, INC. | bez oceny | 2,3B USD | 25,86 USD | — | — | — |
| GMAB | Genmab A/S | A+ | 2,2B USD | 35,32 USD | 2,30 | 3,7B USD | 25,9% |
| AUPH | Aurinia Pharmaceuticals Inc. | A+ | 2,2B USD | 16,44 USD | 7,18 | 311,5M USD | 100,8% |
| OCUL | OCULAR THERAPEUTIX, INC | F- | 2,1B USD | 9,65 USD | — | 52,1M USD | -579,1% |
| ADMA | ADMA BIOLOGICS, INC. | A+ | 2,1B USD | 9,38 USD | 13,40 | 512,3M USD | 33,0% |
| PHVS | Pharvaris N.V. | bez oceny | 2,1B USD | 32,02 USD | — | — | — |
| TRVI | Trevi Therapeutics, Inc. | bez oceny | 2,1B USD | 14,41 USD | — | — | — |
| VCEL | VERICEL CORPORATION | A | 2B USD | 39,71 USD | 84,49 | 306,3M USD | 7,9% |
| KOD | KODIAK SCIENCES INC. | bez oceny | 2B USD | 32,35 USD | — | — | — |
| URGN | UroGen Pharma Ltd. | C | 2B USD | 41,35 USD | — | 188,7M USD | -51,7% |
| NUVB | Nuvation Bio Inc. | C- | 2B USD | 5,74 USD | — | 169,9M USD | -88,2% |
| RXRX | RECURSION PHARMACEUTICALS, INC. | D- | 2B USD | 3,74 USD | — | 54,9M USD | -945,9% |
| PVLA | Palvella Therapeutics, Inc. | bez oceny | 2B USD | 138,16 USD | — | — | — |
| SRPT | SAREPTA THERAPEUTICS, INC. | B- | 2B USD | 18,67 USD | — | 2B USD | -6,9% |
| BHVN | Biohaven Ltd. | bez oceny | 2B USD | 12,99 USD | — | — | — |
| MESO | MESOBLAST LIMITED | C- | 2B USD | 15,12 USD | — | 65,4M USD | -156,2% |
| NKTR | Nektar Therapeutics | F- | 1,9B USD | 57,06 USD | — | 54,6M USD | -287,8% |
| AGIO | AGIOS PHARMACEUTICALS, INC. | C- | 1,9B USD | 32,58 USD | — | 98,3M USD | -418,2% |
| GENB | Generate Biomedicines, Inc. | bez oceny | 1,9B USD | 15,15 USD | — | — | — |
| LKFT | GALAPAGOS NV | B | 1,9B USD | 29,38 USD | 5,30 | 1,3B USD | 28,9% |
| FTRE | FORTREA HOLDINGS INC. | C | 1,9B USD | 19,89 USD | — | 2,7B USD | -3,2% |
| ZYME | ZYMEWORKS INC. | F- | 1,9B USD | 26,52 USD | — | 37,1M USD | -404,0% |
| VIR | Vir Biotechnology, Inc. | C- | 1,8B USD | 10,66 USD | — | 303,2M USD | -83,0% |
| XNCR | Xencor, Inc | F- | 1,8B USD | 23,80 USD | — | 105M USD | -155,6% |
| SEPN | Septerna, Inc. | B | 1,8B USD | 37,77 USD | — | 98,9M USD | -24,5% |
| ZBIO | Zenas BioPharma, Inc. | F- | 1,8B USD | 26,95 USD | — | 10M USD | -4843,8% |
| NVAX | NOVAVAX INC | D | 1,8B USD | 10,63 USD | — | 413,8M USD | -59,9% |
| ABSI | ABSCI CORP | F- | 1,7B USD | 9,74 USD | — | 1,6M USD | -7756,4% |
| NTLA | INTELLIA THERAPEUTICS, INC. | C- | 1,6B USD | 11,75 USD | — | 59,5M USD | -672,2% |
| RAPP | Rapport Therapeutics, Inc. | bez oceny | 1,6B USD | 33,91 USD | — | — | — |
| SNDX | Syndax Pharmaceuticals, Inc. | D- | 1,6B USD | 18,20 USD | — | 252,3M USD | -87,5% |
| NBTX | Nanobiotix S.A. | C- | 1,6B USD | 33,31 USD | — | 37,1M USD | -73,5% |
| STOK | Stoke Therapeutics, Inc. | F- | 1,6B USD | 24,80 USD | — | 27,6M USD | -753,6% |
| IMCR | Immunocore Holdings plc | C- | 1,6B USD | 30,72 USD | — | 430,8M USD | -4,2% |
| ANAB | ANAPTYSBIO, INC. | B+ | 1,5B USD | 51,00 USD | 8,89 | 237,6M USD | 82,4% |
| TSHA | Taysha Gene Therapies, Inc. | F- | 1,5B USD | 4,67 USD | — | 5,5M USD | -2728,0% |
| INVA | INNOVIVA, INC. | B+ | 1,5B USD | 20,74 USD | 5,05 | 440M USD | 81,2% |
| GHRS | GH Research PLC | bez oceny | 1,5B USD | 23,84 USD | — | — | — |
| INBX | INHIBRX BIOSCIENCES, INC. | D- | 1,5B USD | 99,61 USD | — | 1,3M USD | -10 629,3% |
| OMER | OMEROS CORP | bez oceny | 1,5B USD | 20,08 USD | 11,67 | — | — |
| MAZE | MAZE THERAPEUTICS, INC. | F- | 1,4B USD | 26,05 USD | — | 167,5M USD | -79,8% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC. | C | 1,4B USD | 14,50 USD | — | 717,2M USD | -81,7% |
| AVBP | ARRIVENT BIOPHARMA, INC. | bez oceny | 1,4B USD | 28,45 USD | — | — | — |
| AAPG | ASCENTAGE PHARMA GROUP INTERNATIONAL | F- | 1,4B USD | 14,86 USD | — | 85,6M USD | -216,5% |
| ORIC | ORIC PHARMACEUTICALS, INC. | bez oceny | 1,4B USD | 13,16 USD | — | — | — |
| JAGX | JAGUAR HEALTH, INC. | B | 1,3B USD | 7,70 USD | — | 27,8M USD | -132,2% |
| TYRA | Tyra Biosciences, Inc. | bez oceny | 1,3B USD | 21,76 USD | — | — | — |
| DRTS | Alpha Tau Medical Ltd. | bez oceny | 1,3B USD | 14,54 USD | — | — | — |
| DMRA | DAMORA THERAPEUTICS, INC. | bez oceny | 1,3B USD | 20,66 USD | — | — | — |
| BCAX | Bicara Therapeutics Inc. | bez oceny | 1,3B USD | 19,21 USD | — | — | — |
| TRAX | FIRST TRACKS BIOTHERAPEUTICS, INC. | bez oceny | 1,2B USD | 34,42 USD | — | — | — |
| LBRX | LB Pharmaceuticals Inc | bez oceny | 1,2B USD | 37,33 USD | — | — | — |
| REPL | REPLIMUNE GROUP, INC. | bez oceny | 1,2B USD | 12,36 USD | — | — | — |
| IMTX | Immatics N.V. | bez oceny | 1,1B USD | 8,37 USD | — | — | — |
| MRVI | Maravai LifeSciences Holdings, Inc. | D- | 1,1B USD | 7,60 USD | — | 208,8M USD | -37,1% |
| VOR | Vor Biopharma Inc. | bez oceny | 1,1B USD | 18,52 USD | 0,10 | — | — |
| MNKD | MANNKIND CORP | C | 1,1B USD | 3,34 USD | — | 393,6M USD | -11,1% |
| MGTX | MeiraGTx Holdings plc | A | 1B USD | 10,91 USD | 15,37 | 397,5M USD | 19,9% |
| ANRO | Alto Neuroscience, Inc. | bez oceny | 1B USD | 26,49 USD | — | — | — |
| SVRA | Savara Inc | bez oceny | 1B USD | 5,00 USD | — | — | — |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | bez oceny | 1B USD | 12,04 USD | — | — | — |
| AKTS | Aktis Oncology, Inc. | bez oceny | 1B USD | 19,43 USD | — | — | — |
| GLUE | Monte Rosa Therapeutics, Inc. | D- | 1B USD | 11,77 USD | — | 28,7M USD | -560,8% |
| FDMT | 4D Molecular Therapeutics, Inc. | C- | 1B USD | 14,47 USD | — | 92M USD | -194,7% |
| JANX | Janux Therapeutics, Inc. | B- | 996,5M USD | 16,30 USD | — | 24M USD | -427,5% |
| CRVS | Corvus Pharmaceuticals, Inc. | bez oceny | 977,5M USD | 11,62 USD | — | — | — |
| ABUS | Arbutus Biopharma Corp | C+ | 959,6M USD | 4,85 USD | 6,14 | 181,7M USD | 84,2% |
| KURA | KURA ONCOLOGY, INC. | D- | 957,2M USD | 10,76 USD | — | 77,2M USD | -384,3% |
| CGEM | CULLINAN THERAPEUTICS, INC. | bez oceny | 953,1M USD | 14,81 USD | — | — | — |
| JBIO | Jade Biosciences, Inc. | bez oceny | 917,1M USD | 14,42 USD | — | — | — |
| SGP | SpyGlass Pharma, Inc. | bez oceny | 905,4M USD | 27,07 USD | — | — | — |
| RIGL | RIGEL PHARMACEUTICALS, INC. | B+ | 900M USD | 48,18 USD | 2,85 | 276,8M USD | 116,3% |
| ALMS | Alumis Inc. | D- | 897,3M USD | 7,10 USD | — | 7,4M USD | -5933,5% |
| TBPH | Theravance Biopharma, Inc. | B | 884,2M USD | 17,03 USD | 16,86 | 104,3M USD | 51,6% |
| SANA | Sana Biotechnology, Inc. | bez oceny | 881,6M USD | 2,95 USD | — | — | — |
| APMD | Apnimed, Inc. | bez oceny | 878M USD | 21,09 USD | — | — | — |
| ARDX | ARDELYX, INC. | B- | 852,2M USD | 3,42 USD | — | 450,9M USD | -12,4% |
| CADL | CANDEL THERAPEUTICS, INC. | bez oceny | 843,2M USD | 11,02 USD | — | — | — |
| AVTX | AVALO THERAPEUTICS, INC. | F- | 829,7M USD | 15,47 USD | — | 59K USD | -170 055,9% |
| GYRE | Gyre Therapeutics, Inc. | D- | 819,6M USD | 7,35 USD | — | 119,4M USD | -23,6% |
| GERN | GERON CORP | bez oceny | 809,5M USD | 1,26 USD | — | — | — |
| LXRX | LEXICON PHARMACEUTICALS, INC. | C- | 798,7M USD | 1,80 USD | — | 41,5M USD | -147,4% |
| IMMX | IMMIX BIOPHARMA, INC. | bez oceny | 784,8M USD | 10,97 USD | — | — | — |
| SLDB | Solid Biosciences Inc. | bez oceny | 781,7M USD | 7,29 USD | — | — | — |
| ACHV | Achieve Life Sciences, Inc. | bez oceny | 775,9M USD | 7,54 USD | — | — | — |
| OLMA | OLEMA PHARMACEUTICALS, INC. | bez oceny | 765,6M USD | 8,75 USD | — | — | — |
| DSGN | Design Therapeutics, Inc. | F | 758,5M USD | 12,12 USD | — | 0,00 USD | — |
| ACRS | Aclaris Therapeutics, Inc. | D- | 758,1M USD | 5,15 USD | — | 8,2M USD | -921,5% |
| WVE | WAVE LIFE SCIENCES LTD. | F- | 744,8M USD | 3,78 USD | — | 42,7M USD | -473,9% |
| PHAR | Pharming Group N.V. | A | 734M USD | 10,46 USD | 261,50 | 376,1M USD | 0,8% |
| ANNX | ANNEXON, INC. | bez oceny | 719,3M USD | 3,64 USD | — | — | — |
| VSTM | Verastem, Inc. | D- | 701M USD | 7,74 USD | — | 87,5M USD | -231,6% |
| MDXG | MiMedx Group, Inc. | C | 680,7M USD | 4,67 USD | 116,75 | 355,2M USD | 1,8% |
| OABI | OMNIAB, INC. | D- | 670,2M USD | 4,61 USD | — | 38,5M USD | -115,1% |
| CLYM | CLIMB BIO, INC. | bez oceny | 669,7M USD | 11,66 USD | — | — | — |
| NVCT | Nuvectis Pharma, Inc. | bez oceny | 658,8M USD | 20,22 USD | — | — | — |
| ZVRA | Zevra Therapeutics, Inc. | A+ | 655,6M USD | 11,04 USD | 12,00 | 136,1M USD | 42,8% |
| IVA | Inventiva S.A. | F | 651,2M USD | 3,37 USD | — | 5,1M USD | -7899,6% |
| AURA | Aura Biosciences, Inc. | bez oceny | 622,2M USD | 6,00 USD | — | — | — |
| IBO | Impact BioMedical, INC. | A | 613,5M USD | 5,69 USD | 6,47 | 35K USD | 2254,3% |
| CRMD | CORMEDIX INC. | A+ | 611,9M USD | 7,85 USD | 3,83 | 462,2M USD | 40,5% |
| STTK | Shattuck Labs, Inc. | C- | 609,2M USD | 6,07 USD | — | 1M USD | -5256,8% |
| ALT | ALTIMMUNE, INC. | D- | 595,2M USD | 3,06 USD | — | 41K USD | -223 804,9% |
| DNA | GINKGO BIOWORKS HOLDINGS, INC. | D- | 591,2M USD | 10,66 USD | — | 111,9M USD | -260,0% |
| PHAT | PHATHOM PHARMACEUTICALS, INC. | B | 590,6M USD | 7,30 USD | — | 239,7M USD | -41,3% |
| CTMX | CytomX Therapeutics, Inc. | F- | 588,3M USD | 2,70 USD | — | 18,3M USD | -435,2% |
| MNPR | Monopar Therapeutics Inc. | F | 572,1M USD | 85,24 USD | — | 0,00 USD | — |
| ALLO | Allogene Therapeutics, Inc. | B- | 570,1M USD | 1,65 USD | — | 6,8M USD | -2419,5% |
| NGNE | Neurogene Inc. | F | 566,5M USD | 28,31 USD | — | 0,00 USD | — |
| CNTN | CANTON STRATEGIC HOLDINGS, INC. | bez oceny | 545,6M USD | 2,57 USD | — | — | — |
| COAG | Hemab Therapeutics Holdings, Inc. | bez oceny | 542,3M USD | 34,74 USD | — | — | — |
| VALN | Valneva SE | D- | 532,8M USD | 6,14 USD | — | 177,9M USD | -73,7% |
| SLN | Silence Therapeutics plc | C- | 528,2M USD | 11,18 USD | — | 615K USD | -9748,5% |
| PRME | Prime Medicine, Inc. | C- | 526M USD | 2,90 USD | — | 4,6M USD | -4056,4% |
| CBIO | CRESCENT BIOPHARMA, INC. | D- | 519,6M USD | 13,99 USD | — | 10,8M USD | -885,5% |
| PBYI | PUMA BIOTECHNOLOGY, INC. | B+ | 504,3M USD | 9,77 USD | 18,79 | 231,2M USD | 11,6% |
| ANL | Adlai Nortye Ltd. | C | 496,6M USD | 15,53 USD | — | 5M USD | -710,6% |
| ARVN | ARVINAS, INC. | B | 496,3M USD | 7,59 USD | 31,63 | 316,7M USD | 2,9% |
| AUTL | Autolus Therapeutics plc | C- | 493,7M USD | 1,86 USD | — | 117,4M USD | -238,7% |
| RGNX | REGENXBIO Inc. | D- | 488,5M USD | 7,40 USD | — | 174,5M USD | -112,6% |
| CAPR | CAPRICOR THERAPEUTICS, INC. | F- | 486M USD | 8,36 USD | — | 0,00 USD | — |
| PBLS | Parabilis Medicines, Inc. | bez oceny | 485,3M USD | 31,20 USD | — | — | — |
| OCS | Oculis Holding AG | bez oceny | 484,3M USD | 9,27 USD | — | — | — |
| ASMB | Assembly Biosciences, Inc. | B- | 481,9M USD | 23,67 USD | 23,21 | 72,3M USD | -0,1% |
| TECX | TECTONIC THERAPEUTIC, INC. | bez oceny | 462,7M USD | 23,67 USD | — | — | — |
| MPLT | MapLight Therapeutics, Inc. | bez oceny | 443,9M USD | 10,46 USD | — | — | — |
| AVLN | Avalyn Pharma Inc. | bez oceny | 435,8M USD | 28,08 USD | — | — | — |
| EIKN | EIKON THERAPEUTICS, INC. | bez oceny | 429M USD | 7,92 USD | — | — | — |
| DMAC | DiaMedica Therapeutics Inc. | bez oceny | 428,2M USD | 7,94 USD | — | — | — |
| PRTA | PROTHENA CORPORATION PUBLIC LIMITED COMPANY | C- | 425,6M USD | 8,29 USD | — | 54,5M USD | -80,7% |
| KYTX | Kyverna Therapeutics, Inc. | bez oceny | 421,2M USD | 6,81 USD | — | — | — |
| AVIR | Atea Pharmaceuticals, Inc. | bez oceny | 414,7M USD | 5,17 USD | — | — | — |
| SPTX | Seaport Therapeutics, Inc. | bez oceny | 411,4M USD | 21,52 USD | — | — | — |
| RLMD | RELMADA THERAPEUTICS, INC. | bez oceny | 408,5M USD | 3,83 USD | — | — | — |
| SPRY | ARS Pharmaceuticals, Inc. | D- | 405,7M USD | 4,08 USD | — | 116,9M USD | -184,2% |
| YDES | YD Bio Limited | D | 405,6M USD | 5,73 USD | — | 596,8K USD | -1392,6% |
| SGMT | Sagimet Biosciences Inc. | bez oceny | 396,3M USD | 9,24 USD | — | — | — |
| EDIT | EDITAS MEDICINE, INC. | B- | 396,2M USD | 2,58 USD | — | 47M USD | -157,3% |
| IRD | Opus Genetics, Inc. | F- | 396M USD | 4,76 USD | — | 9,9M USD | -1091,8% |
| ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC. | F- | 393,7M USD | 13,85 USD | — | 29,4M USD | -317,6% |
| GALT | GALECTIN THERAPEUTICS INC. | bez oceny | 393,3M USD | 3,90 USD | — | — | — |
| ZURA | ZURA BIO LIMITED | bez oceny | 387,1M USD | 4,04 USD | — | — | — |
| AGEN | AGENUS INC | C | 384,5M USD | 8,54 USD | 3,31 | 132,7M USD | 69,3% |
| RZLT | REZOLUTE, INC. | bez oceny | 377,2M USD | 3,90 USD | — | — | — |
| TTRX | Turn Therapeutics Inc. | bez oceny | 372,1M USD | 12,49 USD | — | — | — |
| FENC | FENNEC PHARMACEUTICALS INC. | C- | 371,9M USD | 10,61 USD | — | 59,2M USD | -5,5% |
| ODTX | Odyssey Therapeutics, Inc. | bez oceny | 369,9M USD | 20,51 USD | — | — | — |
| CCCC | C4 Therapeutics, Inc. | C- | 366,6M USD | 2,98 USD | — | 35M USD | -289,4% |
| OBIO | Orchestra BioMed Holdings, Inc. | F- | 357,6M USD | 5,95 USD | — | 32M USD | -184,6% |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | bez oceny | 356,3M USD | 51,80 USD | — | — | — |
| CABA | CABALETTA BIO, INC. | bez oceny | 351M USD | 2,07 USD | — | — | — |
| SRZN | Surrozen, Inc./DE | D | 347,2M USD | 29,54 USD | — | 11,5M USD | -2885,3% |
| ENTA | ENANTA PHARMACEUTICALS, INC | F- | 346M USD | 11,88 USD | — | 65,3M USD | -96,9% |
| OCGN | OCUGEN, INC. | C | 345,9M USD | 1,02 USD | — | 4,6M USD | -1786,3% |
| ARTV | Artiva Biotherapeutics, Inc. | F- | 341,7M USD | 6,99 USD | — | 0,00 USD | — |
| IMUX | Immunic, Inc. | bez oceny | 339,8M USD | 9,35 USD | — | — | — |
| BNTC | Benitec Biopharma Inc. | D | 334,5M USD | 9,59 USD | — | 0,00 USD | — |
| LRMR | LARIMAR THERAPEUTICS, INC. | bez oceny | 319,4M USD | 3,08 USD | — | — | — |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | bez oceny | 316,7M USD | 3,95 USD | — | — | — |
| VERU | VERU INC. | bez oceny | 313,4M USD | 2,54 USD | — | — | — |
| EYPT | EyePoint, Inc. | F- | 312,1M USD | 3,62 USD | — | 2,8M USD | -10 994,7% |
| GTBP | GT BIOPHARMA, INC. | bez oceny | 310,8M USD | 6,89 USD | 18,61 | — | — |
| PRLD | PRELUDE THERAPEUTICS INC | B- | 309,2M USD | 3,88 USD | — | 22,4M USD | -269,7% |
| ABEO | ABEONA THERAPEUTICS INC. | C- | 308,8M USD | 5,40 USD | — | 25,5M USD | -246,4% |
| EVMN | Evommune, Inc. | D- | 308,1M USD | 8,49 USD | — | 10M USD | -946,7% |
| VNDA | VANDA PHARMACEUTICALS INC. | F- | 305,3M USD | 5,05 USD | — | 215,7M USD | -127,4% |
| IPSC | Century Therapeutics, Inc. | B- | 302,4M USD | 1,67 USD | — | 109,2M USD | -100,6% |
| SABS | SAB BIOTHERAPEUTICS, INC. | F- | 299,3M USD | 3,29 USD | — | 0,00 USD | — |
| XFOR | X4 PHARMACEUTICALS, INC | D- | 298,4M USD | 3,01 USD | — | 15,8M USD | -568,8% |
| KARD | Kardigan, Inc. | bez oceny | 294,3M USD | 14,79 USD | — | — | — |
| UPB | UPSTREAM BIO, INC. | D- | 293,6M USD | 5,36 USD | — | 3,2M USD | -4955,7% |
| CTNM | Contineum Therapeutics, Inc. | D | 290,1M USD | 12,56 USD | — | 0,00 USD | — |
| IKT | Inhibikase Therapeutics, Inc. | F | 287,4M USD | 2,06 USD | — | 0,00 USD | — |
| EPRX | EUPRAXIA PHARMACEUTICALS INC. | F | 285,5M USD | 8,01 USD | — | 0,00 USD | — |
| FULC | FULCRUM THERAPEUTICS, INC. | F- | 285,4M USD | 3,74 USD | — | 0,00 USD | — |
| RCKT | Rocket Pharmaceuticals, Inc. | D | 284,9M USD | 2,60 USD | — | 0,00 USD | — |
| LIMN | LIMINATUS PHARMA, INC. | bez oceny | 281,7M USD | 4,20 USD | — | — | — |
| FATE | FATE THERAPEUTICS INC | D- | 281,6M USD | 2,35 USD | — | 6,5M USD | -1941,1% |
| IMRX | Immuneering Corporation | bez oceny | 276,2M USD | 4,27 USD | — | — | — |
| IVVD | INVIVYD, INC. | C- | 275,4M USD | 0,93 USD | — | 58,4M USD | -183,9% |
| HELP | CYBIN INC. | bez oceny | 272,4M USD | 12,61 USD | — | — | — |
| LXEO | Lexeo Therapeutics, Inc. | bez oceny | 271,6M USD | 3,31 USD | — | — | — |
| GLSI | GREENWICH LIFESCIENCES, INC. | bez oceny | 267,4M USD | 18,22 USD | — | — | — |
| STRO | SUTRO BIOPHARMA, INC. | F | 265M USD | 15,98 USD | — | 45,7M USD | -395,2% |
| QTTB | Q32 Bio Inc. | B | 261,1M USD | 8,77 USD | 2,80 | 53,7M USD | 62,9% |
| LCTX | Lineage Cell Therapeutics, Inc. | D- | 260,5M USD | 1,03 USD | — | 13,1M USD | -246,6% |
| BCYC | Bicycle Therapeutics plc | D- | 257M USD | 3,69 USD | — | 61,2M USD | -311,1% |
| ACIU | AC IMMUNE SA | F- | 256,4M USD | 2,52 USD | — | 4,3M USD | -1207,8% |
| OBX | OBSIDIAN THERAPEUTICS, INC. | F | 254M USD | 12,86 USD | — | 0,00 USD | — |
| PALI | PALISADE BIO, INC. | C- | 252,7M USD | 1,45 USD | — | 500K USD | -6388,2% |
| INDP | Indaptus Therapeutics, Inc. | bez oceny | 246,8M USD | 3,85 USD | — | — | — |
| CAMP | CAMP4 Therapeutics Corporation | B- | 246M USD | 3,92 USD | — | 3,5M USD | -3065,9% |
| LYEL | Lyell Immunopharma, Inc. | D- | 241,4M USD | 9,85 USD | — | 27K USD | -920 285,2% |
| TRDA | ENTRADA THERAPEUTICS, INC. | F- | 239,8M USD | 6,16 USD | — | 4,7M USD | -3537,7% |
| PYXS | Pyxis Oncology, Inc. | D- | 238,5M USD | 2,86 USD | — | 13,9M USD | -640,3% |
| MGNX | MACROGENICS, INC. | C- | 238,2M USD | 3,74 USD | — | 167,7M USD | -8,7% |
| SION | SIONNA THERAPEUTICS, INC. | bez oceny | 236,5M USD | 5,23 USD | — | — | — |
| KROS | Keros Therapeutics, Inc. | D- | 230,4M USD | 11,62 USD | — | 15M USD | -553,9% |
| CUE | Cue Biopharma, Inc. | D- | 228,2M USD | 31,41 USD | — | 37,7M USD | -435,8% |
| NRSN | NeuroSense Therapeutics Ltd. | bez oceny | 226,3M USD | 6,95 USD | — | — | — |
| CGEN | COMPUGEN LTD | B+ | 225M USD | 2,38 USD | 6,26 | 74M USD | 47,6% |
| RNAC | Cartesian Therapeutics, Inc. | F | 224,2M USD | 7,41 USD | — | 1,5M USD | -10 283,8% |
| ZLAB | ZAI LAB LIMITED | C- | 221,3M USD | 24,98 USD | — | 449,6M USD | -41,9% |
| AVXL | ANAVEX LIFE SCIENCES CORP. | bez oceny | 220,6M USD | 2,38 USD | — | — | — |
| PLX | Protalix BioTherapeutics, Inc. | A+ | 219,2M USD | 2,72 USD | 11,83 | 80,6M USD | 23,5% |
| ALEC | Alector, Inc. | D- | 217,7M USD | 1,95 USD | — | 13,9M USD | -850,1% |
| MLEC | MOOLEC SCIENCE SA | D | 217,4M USD | 5,60 USD | — | 333,6M USD | -52,9% |
| ELDN | Eledon Pharmaceuticals, Inc. | bez oceny | 215,3M USD | 2,65 USD | — | — | — |
| WHWK | WHITEHAWK THERAPEUTICS, INC. | F | 213,2M USD | 3,74 USD | — | 0,00 USD | — |
| FHTX | Foghorn Therapeutics Inc. | B | 207,8M USD | 3,50 USD | — | 36,7M USD | -175,8% |
| CMPX | COMPASS THERAPEUTICS, INC. | F | 203,5M USD | 1,13 USD | — | 0,00 USD | — |
| NKTX | Nkarta, Inc. | D | 197M USD | 2,75 USD | — | 0,00 USD | — |
| ORMP | ORAMED PHARMACEUTICALS INC. | C | 196,8M USD | 4,73 USD | 1,15 | 2M USD | 8743,5% |
| TARA | Protara Therapeutics, Inc. | bez oceny | 193,8M USD | 3,28 USD | — | — | — |
| ZNTL | Zentalis Pharmaceuticals, Inc. | F | 193,5M USD | 2,70 USD | — | 0,00 USD | — |
| SLGL | Sol-Gel Technologies Ltd. | B | 186,3M USD | 66,85 USD | — | 1,8M USD | -341,3% |
| ACOG | Alpha Cognition Inc. | D- | 184,5M USD | 8,47 USD | — | 15,3M USD | -153,6% |
| ANTX | AN2 Therapeutics, Inc. | bez oceny | 184,2M USD | 4,88 USD | — | — | — |
| ALXO | ALX ONCOLOGY HOLDINGS INC | bez oceny | 181,1M USD | 1,31 USD | — | — | — |
| PEPG | PEPGEN INC. | bez oceny | 179,4M USD | 2,59 USD | — | — | — |
| MDWD | MEDIWOUND LTD. | F- | 177,6M USD | 13,84 USD | — | 11,9M USD | -170,1% |
| CHRS | Coherus Oncology, Inc. | B | 174,6M USD | 1,13 USD | — | 50,9M USD | -259,4% |
| PRQR | ProQR Therapeutics N.V. | C- | 173,8M USD | 1,65 USD | — | 20,9M USD | -229,7% |
| MOLN | MOLECULAR PARTNERS AG | F- | 173,6M USD | 4,30 USD | — | 5,2M USD | -1437,4% |
| ADAG | Adagene Inc. | C- | 173,5M USD | 2,93 USD | — | 7,7M USD | -229,6% |
| DTIL | PRECISION BIOSCIENCES INC | D- | 171,7M USD | 6,22 USD | — | 45,1M USD | -117,0% |
| OVID | Ovid Therapeutics Inc. | C- | 170,1M USD | 2,40 USD | — | 1,6M USD | -2178,9% |
| TNXP | TONIX PHARMACEUTICALS HOLDING CORP. | D- | 169,1M USD | 9,86 USD | — | 29,1M USD | -548,6% |
| VYGR | Voyager Therapeutics, Inc. | F- | 165,1M USD | 2,68 USD | — | 34,5M USD | -312,6% |
| NERV | Minerva Neurosciences, Inc. | F | 162,3M USD | 3,40 USD | — | 0,00 USD | — |
| ABOS | Acumen Pharmaceuticals, Inc. | bez oceny | 162M USD | 2,24 USD | — | — | — |
| IPHA | Innate Pharma SA | F- | 159,3M USD | 1,70 USD | — | 10,2M USD | -546,1% |
| NBP | NovaBridge Biosciences | bez oceny | 159,2M USD | 1,38 USD | — | — | — |
| HUMA | Humacyte, Inc. | C- | 154,8M USD | 0,56 USD | — | 2,1M USD | -4560,8% |
| NGEN | NERVGEN PHARMA CORP. | bez oceny | 154,5M USD | 1,94 USD | — | — | — |
| MENS | Jyong Biotech Ltd. | bez oceny | 154,3M USD | 2,03 USD | — | — | — |
| CURX | Curanex Pharmaceuticals Inc | bez oceny | 148,7M USD | 4,74 USD | — | — | — |
| CLLS | Cellectis S.A. | C- | 147,4M USD | 1,47 USD | — | 72,9M USD | -92,7% |
| BRVE | Braveheart Bio, Inc. | bez oceny | 147,1M USD | 20,62 USD | — | — | — |
| KRSA | CYCLERION THERAPEUTICS, INC. | F- | 145,1M USD | 31,00 USD | — | 1,9M USD | -353,0% |
| CDXS | Codexis, Inc. | D- | 144,5M USD | 1,32 USD | — | 77,7M USD | -39,6% |
| RNA | Atrium Therapeutics, Inc. | bez oceny | 141,8M USD | 8,29 USD | — | — | — |
| KRRO | Korro Bio, Inc. | C- | 140,9M USD | 9,57 USD | — | 2,4M USD | -4477,1% |
| SPRB | Spruce Biosciences, Inc. | F | 140M USD | 48,72 USD | — | 0,00 USD | — |
| ARMP | ARMATA PHARMACEUTICALS, INC. | bez oceny | 139,1M USD | 3,74 USD | — | — | — |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | bez oceny | 138,1M USD | 7,14 USD | — | — | — |
| TNYA | Tenaya Therapeutics, Inc. | bez oceny | 136,7M USD | 0,61 USD | — | — | — |
| RANI | RANI THERAPEUTICS HOLDINGS, INC. | C- | 136,7M USD | 0,76 USD | — | 4,9M USD | -618,0% |
| IFRX | InflaRx N.V. | F- | 136,6M USD | 1,89 USD | — | 33,4K USD | -155 582,1% |
| ENTX | ENTERA BIO LTD. | F | 134,8M USD | 2,75 USD | — | 0,00 USD | — |
| MSLE | Satellos Bioscience Inc. | bez oceny | 134,5M USD | 8,70 USD | — | — | — |
| HURA | TuHURA BIOSCIENCES, INC./NV | F | 133,8M USD | 2,10 USD | — | 0,00 USD | — |
| CRBU | Caribou Biosciences, Inc. | D- | 132,9M USD | 1,24 USD | — | 10M USD | -1030,4% |
| ENGN | enGene Therapeutics Inc. | bez oceny | 131,4M USD | 1,96 USD | — | — | — |
| UNCY | UNICYCIVE THERAPEUTICS, INC. | bez oceny | 130,8M USD | 4,70 USD | — | — | — |
| NMRA | NEUMORA THERAPEUTICS, INC. | bez oceny | 127,3M USD | 0,68 USD | — | — | — |
| MNOV | MEDICINOVA, INC. | C- | 127M USD | 2,58 USD | — | 920,5K USD | -1168,2% |
| VOGX | Vogenx, Inc. | bez oceny | 123,9M USD | 22,73 USD | — | — | — |
| LENZ | LENZ THERAPEUTICS, INC. | D- | 123M USD | 3,92 USD | — | 19,1M USD | -660,1% |
| NAUT | Nautilus Biotechnology, Inc. | bez oceny | 122,5M USD | 0,96 USD | — | — | — |
| INO | INOVIO PHARMACEUTICALS, INC. | D | 122M USD | 1,18 USD | — | 0,00 USD | — |
| TLSA | Tiziana Life Sciences Ltd | bez oceny | 121,7M USD | 1,01 USD | — | — | — |
| COYA | Coya Therapeutics, Inc. | F- | 119,2M USD | 5,08 USD | — | 8M USD | -270,2% |
| OKUR | ONKURE THERAPEUTICS, INC. | C | 117,4M USD | 2,90 USD | — | 0,00 USD | — |
| GNLX | GENELUX CORPORATION | F- | 112,2M USD | 2,48 USD | — | 8K USD | -444 950,0% |
| VANI | Vivani Medical, Inc. | F | 111,9M USD | 1,24 USD | — | 0,00 USD | — |
| AARD | AARDVARK THERAPEUTICS, INC. | F | 110,7M USD | 5,06 USD | — | 0,00 USD | — |
| CNXU | CONEXEU SCIENCES INC. | bez oceny | 109,7M USD | 3,89 USD | — | — | — |
| BDTX | BLACK DIAMOND THERAPEUTICS, INC. | D | 108M USD | 1,88 USD | — | 0,00 USD | — |
| EQ | EQUILLIUM, INC. | C- | 105,9M USD | 1,67 USD | — | 41,1M USD | -43,8% |
| SEER | SEER, INC. | D- | 105,8M USD | 1,91 USD | — | 14,2M USD | -478,0% |
| PLYX | Polaryx Therapeutics, Inc. | bez oceny | 104,2M USD | 2,09 USD | — | — | — |
| QNCX | Quince Therapeutics, Inc. | bez oceny | 102,2M USD | 31,00 USD | — | — | — |
| PMN | PROMIS NEUROSCIENCES INC. | bez oceny | 101,1M USD | 11,27 USD | — | — | — |
| PROK | ProKidney Corp. | F- | 98,5M USD | 1,60 USD | — | 818K USD | -10 288,4% |
| MIST | Milestone Pharmaceuticals Inc. | bez oceny | 98,2M USD | 0,79 USD | — | — | — |
| FTH | Faeth Therapeutics, Inc. | bez oceny | 97,5M USD | 28,00 USD | — | — | — |
| NTRB | NUTRIBAND INC. | F- | 97,2M USD | 8,00 USD | — | 1,6M USD | -430,4% |
| ANIX | ANIXA BIOSCIENCES, INC. | bez oceny | 96,6M USD | 2,78 USD | — | — | — |
| CRDF | CARDIFF ONCOLOGY, INC. | F- | 96,5M USD | 1,24 USD | — | 508K USD | -7884,1% |
| BMEA | Biomea Fusion, Inc. | bez oceny | 95,7M USD | 1,32 USD | — | — | — |
| PYPD | PolyPid Ltd | bez oceny | 95M USD | 5,22 USD | 2,50 | — | — |
| NRXS | NEURAXIS, INC. | D- | 94,9M USD | 7,56 USD | — | 5,3M USD | -144,4% |
| ICCC | ImmuCell Corporation | A | 90,1M USD | 9,93 USD | 141,79 | 30,7M USD | 2,6% |
| ACRV | Acrivon Therapeutics, Inc. | bez oceny | 90M USD | 2,10 USD | — | — | — |
| CGTX | Cognition Therapeutics, Inc. | bez oceny | 89,1M USD | 0,94 USD | — | — | — |
| ATRA | ATARA BIOTHERAPEUTICS, INC. | D | 88,4M USD | 8,81 USD | — | 6,2M USD | -269,4% |
| RLYB | RALLYBIO CORPORATION | D | 88,3M USD | 16,62 USD | 3,38 | 646K USD | 7051,2% |
| ONCY | ONCOLYTICS BIOTECH INC. | bez oceny | 87,1M USD | 0,68 USD | — | — | — |
| NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | D | 85,8M USD | 3,31 USD | — | 40K USD | -118 029,5% |
| PTHS | Pelthos Therapeutics Inc. | C- | 85M USD | 22,19 USD | — | 50,4M USD | -171,4% |
| TELO | Telomir Pharmaceuticals, Inc. | bez oceny | 84,6M USD | 1,23 USD | — | — | — |
| ACET | Adicet Bio, Inc. | bez oceny | 84,4M USD | 9,02 USD | — | — | — |
| FBIO | Fortress Biotech, Inc. | B | 84,4M USD | 2,28 USD | 0,86 | 68,5M USD | 163,3% |
| LEXX | LEXARIA BIOSCIENCE CORP. | D- | 81,3M USD | 3,28 USD | — | 194K USD | -3985,6% |
| GANX | GAIN THERAPEUTICS, INC | bez oceny | 77,7M USD | 1,78 USD | — | — | — |
| GUTS | Fractyl Health, Inc. | F- | 77,3M USD | 0,49 USD | — | 0,00 USD | — |
| OSTX | OS THERAPIES INCORPORATED | bez oceny | 76,6M USD | 1,66 USD | — | — | — |
| IBIO | IBIO, INC. | D- | 76,5M USD | 1,19 USD | — | 100K USD | -33 044,0% |
| VRCA | Verrica Pharmaceuticals Inc. | C- | 75,1M USD | 4,37 USD | — | 30,3M USD | -102,8% |
| RNXT | RENOVORX, INC. | D- | 74,9M USD | 1,66 USD | — | 2M USD | -621,7% |
| ATTO | Attovia Therapeutics, Inc. | bez oceny | 74,6M USD | 17,78 USD | — | — | — |
| BSEM | BioStem Technologies, Inc. | D- | 73,9M USD | 4,14 USD | — | 34,6M USD | -81,8% |
| MAIA | MAIA Biotechnology, Inc. | F | 73M USD | 1,20 USD | — | 0,00 USD | — |
| ALDX | ALDEYRA THERAPEUTICS, INC. | bez oceny | 72,7M USD | 1,21 USD | — | — | — |
| OKYO | OKYO Pharma Limited | bez oceny | 72,4M USD | 1,38 USD | — | — | — |
| SPRO | Spero Therapeutics, Inc. | C | 71,6M USD | 1,23 USD | 8,79 | 47M USD | 15,7% |
| PMVP | PMV PHARMACEUTICALS, INC. | bez oceny | 71,1M USD | 1,33 USD | — | — | — |
| CING | Cingulate Inc. | bez oceny | 70,2M USD | 4,83 USD | — | — | — |
| LNAI | Lunai Bioworks Inc. | bez oceny | 70M USD | 1,93 USD | — | — | — |
| LONA | LeonaBio, Inc. | bez oceny | 69,5M USD | 3,25 USD | — | — | — |
| KLRS | KALARIS THERAPEUTICS, INC. | bez oceny | 69,5M USD | 2,92 USD | — | — | — |
| CSBR | CHAMPIONS ONCOLOGY, INC. | D- | 68,2M USD | 4,90 USD | — | 60,7M USD | -1,8% |
| CNTB | Connect Biopharma Holdings Limited | C- | 68M USD | 1,08 USD | — | 3M USD | -2336,3% |
| TENX | TENAX THERAPEUTICS, INC. | F | 67,7M USD | 1,81 USD | — | 0,00 USD | — |
| PLRX | PLIANT THERAPEUTICS, INC. | D | 66,9M USD | 1,08 USD | — | 0,00 USD | — |
| XBIT | XBIOTECH INC. | bez oceny | 66,2M USD | 2,17 USD | — | — | — |
| ALPS | ALPS GROUP INC | bez oceny | 65,9M USD | 0,40 USD | — | — | — |
| BRTX | BIORESTORATIVE THERAPIES, INC. | F- | 65M USD | 2,55 USD | — | 357,9K USD | -3089,6% |
| RNTX | Rein Therapeutics, Inc. | F | 64,6M USD | 0,75 USD | — | 0,00 USD | — |
| HYFT | MindWalk Holdings Corp. | C- | 64,5M USD | 1,38 USD | — | 19,8M USD | -43,6% |
| HYPD | HYPERION DEFI, INC. | D+ | 62,8M USD | 4,04 USD | — | 1,4M USD | 474,9% |
| INKT | MiNK Therapeutics, Inc. | bez oceny | 62,2M USD | 12,18 USD | — | — | — |
| ELOX | ELOXX PHARMACEUTICALS, INC. | D | 60,7M USD | 15,03 USD | — | 0,00 USD | — |
| BOLD | BOUNDLESS BIO, INC. | bez oceny | 60,5M USD | 2,66 USD | — | — | — |
| OTLK | OUTLOOK THERAPEUTICS, INC. | F+ | 59,6M USD | 0,64 USD | — | -1,2M USD | 5253,5% |
| SKYE | Skye Bioscience, Inc. | bez oceny | 59,2M USD | 1,67 USD | — | — | — |
| MREO | MEREO BIOPHARMA GROUP PLC | B | 59,1M USD | 0,37 USD | — | 500K USD | -5619,8% |
| EXOZ | EXOZYMES INC. | bez oceny | 58M USD | 6,25 USD | — | — | — |
| ALGS | Aligos Therapeutics, Inc. | D- | 57,4M USD | 5,51 USD | — | 3,7M USD | -2031,1% |
| INMB | INMUNE BIO INC. | D- | 56,3M USD | 2,03 USD | — | 50K USD | -36 832,0% |
| BCAB | BIOATLA, INC. | bez oceny | 56,1M USD | 1,74 USD | — | — | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | C- | 55,9M USD | 0,29 USD | — | 151,2M USD | -22,5% |
| ANVS | Annovis Bio, Inc. | F | 55,8M USD | 1,31 USD | — | 0,00 USD | — |
| CLNN | Clene Inc. | D | 55,2M USD | 4,30 USD | — | 197K USD | -20 059,9% |
| CLGN | CollPlant Biotechnologies Ltd | B- | 54,4M USD | 4,25 USD | — | 2,4M USD | -484,6% |
| IMA | ImageneBio, Inc. | D- | 53,6M USD | 4,72 USD | — | 800K USD | -6560,5% |
| SER | Serina Therapeutics, Inc. | D | 53,1M USD | 2,09 USD | — | 130K USD | -16 288,5% |
| SCTX | SCRIBE THERAPEUTICS INC. | bez oceny | 52,5M USD | 21,28 USD | — | — | — |
| XLO | Xilio Therapeutics, Inc. | C- | 52,3M USD | 9,04 USD | — | 64,1M USD | -34,1% |
| BLSM | BlossomHill Therapeutics, Inc. | bez oceny | 52,3M USD | 19,75 USD | — | — | — |
| LITS | Lite Strategy, Inc. | D | 49M USD | 1,44 USD | — | 0,00 USD | — |
| TIL | Instil Bio, Inc. | C- | 48,6M USD | 7,17 USD | — | 9M USD | -337,7% |
| ELTX | Elicio Therapeutics, Inc. | bez oceny | 48,4M USD | 1,84 USD | — | — | — |
| TVGN | Tevogen Inc. | bez oceny | 47,2M USD | 7,25 USD | — | — | — |
| HOWL | WEREWOLF THERAPEUTICS, INC. | bez oceny | 46,7M USD | 0,96 USD | — | — | — |
| DWTX | Dogwood Therapeutics, Inc. | bez oceny | 46,2M USD | 1,36 USD | — | — | — |
| PDSB | PDS Biotechnology Corp | bez oceny | 44,6M USD | 0,80 USD | — | — | — |
| GRCE | Grace Therapeutics, Inc. | bez oceny | 44,6M USD | 2,12 USD | — | — | — |
| TCRX | TSCAN THERAPEUTICS, INC. | F- | 44,2M USD | 0,34 USD | — | 7,1M USD | -1655,4% |
| MGX | Metagenomi Therapeutics, Inc. | D- | 43,4M USD | 1,15 USD | — | 22,3M USD | -418,5% |
| KAPA | KAIROS PHARMA, LTD. | bez oceny | 40,8M USD | 1,72 USD | — | — | — |
| CELU | Celularity Inc. | C | 39,9M USD | 1,38 USD | — | 26,6M USD | -345,4% |
| ATHE | ALTERITY THERAPEUTICS LTD | bez oceny | 39,1M USD | 3,67 USD | — | — | — |
| EDSA | EDESA BIOTECH, INC. | bez oceny | 38,7M USD | 4,01 USD | — | — | — |
| IMMP | Immutep Limited | D- | 38,5M USD | 0,26 USD | — | 7,3M USD | -594,6% |
| CRVO | CervoMed Inc. | F- | 38,4M USD | 2,54 USD | — | 331,3K USD | -9160,9% |
| ATNM | ACTINIUM PHARMACEUTICALS, INC. | D+ | 37,7M USD | 1,20 USD | 3,33 | 90K USD | 12 564,4% |
| ELAB | PMGC HOLDINGS INC. | D- | 37M USD | 4,57 USD | — | 2,6M USD | -523,0% |
| FLNA | Filana Therapeutics, Inc. | bez oceny | 36,1M USD | 0,75 USD | — | — | — |
| NIKI | Niki BioSolutions, Inc. | bez oceny | 35M USD | 4,76 USD | — | — | — |
| MCRB | Seres Therapeutics, Inc. | D- | 35M USD | 3,52 USD | — | 1,9M USD | -1192,9% |
| ICU | SeaStar Medical Holding Corp | D- | 34,1M USD | 3,42 USD | — | 1,7M USD | -795,5% |
| BYSI | BeyondSpring Inc. | D | 32M USD | 0,78 USD | — | 0,00 USD | — |
| CNTX | CONTEXT THERAPEUTICS INC. | bez oceny | 31,8M USD | 0,35 USD | — | — | — |
| NNVC | NANOVIRICIDES, INC. | F | 31,2M USD | 1,44 USD | — | 0,00 USD | — |
| ABVC | ABVC BioPharma, Inc. | D- | 30,1M USD | 1,13 USD | — | 296K USD | -2400,9% |
| ATYR | aTYR PHARMA INC | F- | 29,9M USD | 0,31 USD | — | 190K USD | -32 003,7% |
| CVM | CEL-SCI CORPORATION | bez oceny | 29,4M USD | 1,67 USD | — | — | — |
| IGC | IGC PHARMA, INC. | C- | 29,2M USD | 0,28 USD | — | 1,3M USD | -560,3% |
| ENLV | Enlivex Ltd. | bez oceny | 29M USD | 0,60 USD | 0,02 | — | — |
| CALC | CalciMedica, Inc. | bez oceny | 28,8M USD | 1,75 USD | — | — | — |
| KYNB | KYNTRA BIO, INC. | F | 28,1M USD | 6,94 USD | 0,15 | 4,6M USD | 3967,8% |
| EVAX | Evaxion A/S | B- | 27,9M USD | 3,34 USD | — | 7,5M USD | -102,4% |
| NRXP | NRX Pharmaceuticals, Inc. | B | 26,5M USD | 3,00 USD | — | 3,4M USD | -691,8% |
| APRE | Aprea Therapeutics, Inc. | bez oceny | 26M USD | 0,76 USD | — | — | — |
| APLM | Apollomics Inc. | B | 24,7M USD | 22,35 USD | — | 8,5M USD | -128,7% |
| GRDX | GRIDAI TECHNOLOGIES CORP | F- | 24,5M USD | 3,43 USD | — | 36,3K USD | -56 864,0% |
| NXTC | NEXTCURE, INC | bez oceny | 23,3M USD | 5,08 USD | — | — | — |
| COCP | COCRYSTAL PHARMA, INC. | bez oceny | 22,5M USD | 1,17 USD | — | — | — |
| YARW | YARROW BIOSCIENCE, INC. | C- | 21,9M USD | 25,54 USD | — | 570K USD | -4646,1% |
| ESLA | ESTRELLA IMMUNOPHARMA, INC. | bez oceny | 20,9M USD | 0,48 USD | — | — | — |
| JSPR | JASPER THERAPEUTICS, INC. | bez oceny | 20,3M USD | 0,61 USD | — | — | — |
| MRKR | MARKER THERAPEUTICS, INC. | D- | 19,2M USD | 1,15 USD | — | 3,9M USD | -220,5% |
| ATOS | ATOSSA THERAPEUTICS, INC. | bez oceny | 19M USD | 1,90 USD | — | — | — |
| CNSP | CNS Pharmaceuticals, Inc. | bez oceny | 18,6M USD | 4,93 USD | — | — | — |
| PTN | PALATIN TECHNOLOGIES, INC. | B | 18M USD | 10,10 USD | — | 12,9M USD | -48,6% |
| LPCN | LIPOCINE INC. | C- | 17,3M USD | 2,10 USD | — | 1,6M USD | -755,1% |
| BCTX | BRIACELL THERAPEUTICS CORP. | bez oceny | 17M USD | 4,32 USD | — | — | — |
| CLRB | Cellectar Biosciences, Inc. | bez oceny | 17M USD | 1,80 USD | — | — | — |
| TVRD | TVARDI THERAPEUTICS, INC. | C- | 16,9M USD | 1,27 USD | — | 7,6M USD | -344,2% |
| KTTA | PASITHEA THERAPEUTICS CORP. | bez oceny | 16,7M USD | 0,50 USD | — | — | — |
| ACTU | Actuate Therapeutics, Inc. | bez oceny | 16,3M USD | 0,68 USD | — | — | — |
| BCDA | BioCardia, Inc. | F | 15,9M USD | 1,05 USD | — | 0,00 USD | — |
| CTXR | Citius Pharmaceuticals, Inc. | bez oceny | 15,9M USD | 0,58 USD | — | — | — |
| LTGO | Latigo Biotherapeutics, Inc. | bez oceny | 15,8M USD | 17,15 USD | — | — | — |
| LTRN | Lantern Pharma Inc. | bez oceny | 15,6M USD | 1,22 USD | — | — | — |
| CMMB | SNOWDRIFT PARENT CORPORATION | bez oceny | 15,5M USD | 2,16 USD | 120,00 | — | — |
| KZIA | Kazia Therapeutics Limited. | F | 15,5M USD | 9,57 USD | 8,43 | 29,5K USD | -54 287,3% |
| PASG | PASSAGE BIO, INC. | bez oceny | 15,4M USD | 4,80 USD | — | — | — |
| DYAI | DYADIC INTERNATIONAL INC | F- | 15,2M USD | 0,42 USD | — | 3,8M USD | -200,5% |
| CNSY | CERENOME, INC. | F- | 15,1M USD | 1,99 USD | — | 4,2M USD | -620,7% |
| HIND | VYOME HOLDINGS, INC. | F- | 14,3M USD | 2,04 USD | — | 129,7K USD | -8716,8% |
| LSTA | LISATA THERAPEUTICS, INC. | C- | 14,2M USD | 1,58 USD | — | 100K USD | -14 621,0% |
| NCEL | NewcelX Ltd. | bez oceny | 14,1M USD | 2,95 USD | 1,36 | — | — |
| AEON | AEON Biopharma, Inc. | bez oceny | 13,1M USD | 0,26 USD | — | — | — |
| RADX | Radiopharm Theranostics Limited | F- | 13M USD | 1,65 USD | — | 3,6M USD | -1055,3% |
| PLUR | Pluri Inc. | D | 12,5M USD | 1,01 USD | — | 1M USD | -2344,6% |
| INTS | INTENSITY THERAPEUTICS, INC. | bez oceny | 12,4M USD | 3,80 USD | — | — | — |
| TPST | Tempest Therapeutics, Inc. | bez oceny | 12,3M USD | 0,83 USD | — | — | — |
| VTGN | VISTAGEN THERAPEUTICS, INC. | F- | 12,1M USD | 0,27 USD | — | 2,5M USD | -2702,6% |
| BIVI | BioVie Inc. | bez oceny | 12,1M USD | 1,61 USD | — | — | — |
| DARE | Dare Bioscience, Inc. | C- | 11,9M USD | 0,78 USD | — | 1,4M USD | -804,4% |
| INAB | IN8BIO, INC. | bez oceny | 11,8M USD | 1,20 USD | — | — | — |
| MBRX | Moleculin Biotech, Inc. | D | 11,7M USD | 0,60 USD | — | 0,00 USD | — |
| KPRX | KIORA PHARMACEUTICALS, INC. | D | 11,6M USD | 2,63 USD | — | 0,00 USD | — |
| BLRX | BioLineRx Ltd | C- | 11,3M USD | 2,60 USD | — | 1,2M USD | -171,7% |
| GDTC | CytoMed Therapeutics Limited | D- | 11,3M USD | 0,96 USD | — | 253,9K USD | -1227,1% |
| ADIL | Adial Pharmaceuticals, Inc. | bez oceny | 11,1M USD | 4,22 USD | — | — | — |
| MTVA | METAVIA INC. | bez oceny | 10,9M USD | 1,66 USD | — | — | — |
| SNTI | Senti Biosciences Holdings, Inc. | F- | 10,3M USD | 0,33 USD | — | 22K USD | -225 290,9% |
| TOVX | Theriva Biologics, Inc. | bez oceny | 10,1M USD | 0,22 USD | — | — | — |
| IMRN | IMMURON LIMITED | D- | 9,4M USD | 1,16 USD | — | 5,1M USD | -71,6% |
| FBLG | FibroBiologics, Inc. | bez oceny | 9,3M USD | 1,39 USD | — | — | — |
| KALA | KALA BIO, INC. | F | 9,2M USD | 0,48 USD | — | 0,00 USD | — |
| VRAX | Virax Biolabs Group Ltd | C- | 8,9M USD | 2,40 USD | — | 6,3K USD | -95 739,2% |
| ALZN | ALZAMEND NEURO, INC. | bez oceny | 8,8M USD | 1,83 USD | — | — | — |
| TRAW | Traws Pharma, Inc. | C- | 8,7M USD | 0,56 USD | — | 2,8M USD | -773,0% |
| SNGX | SOLIGENIX, INC. | D- | 8,4M USD | 0,38 USD | — | 119,4K USD | -8577,8% |
| ENSC | ENSYSCE BIOSCIENCES, INC. | D- | 8M USD | 0,41 USD | — | 4,5M USD | -280,5% |
| XCUR | EXICURE, INC. | F | 8M USD | 1,22 USD | — | 0,00 USD | — |
| IMNN | Imunon, Inc. | bez oceny | 7,9M USD | 1,41 USD | — | — | — |
| ALLR | Allarity Therapeutics, Inc. | B- | 7,9M USD | 1,03 USD | — | 320K USD | -3854,4% |
| ARTL | ARTELO BIOSCIENCES, INC. | bez oceny | 7,9M USD | 4,54 USD | — | — | — |
| CBUS | Cibus, Inc. | C- | 7,6M USD | 1,52 USD | — | 4,3M USD | -2258,9% |
| ACXP | Acurx Pharmaceuticals, Inc. | bez oceny | 7,2M USD | 1,36 USD | — | — | — |
| BOLT | Bolt Biotherapeutics, Inc. | D- | 6,9M USD | 3,58 USD | — | 4,7M USD | -611,5% |
| CELZ | Creative Medical Technology Holdings, Inc. | D- | 6,8M USD | 1,03 USD | — | 3K USD | -201 355,4% |
| ENVB | ENVERIC BIOSCIENCES, INC. | bez oceny | 6,7M USD | 1,50 USD | — | — | — |
| PULM | PULMATRIX, INC. | B- | 5,9M USD | 1,61 USD | — | 7,8M USD | -51,4% |
| CDIO | Cardio Diagnostics Holdings, Inc. | C- | 5,8M USD | 1,95 USD | — | 14,5K USD | -44 771,8% |
| AGMB | AgomAb Therapeutics NV | bez oceny | 5,7M USD | 10,51 USD | — | — | — |
| ERNA | Ernexa Therapeutics Inc. | B- | 5,6M USD | 3,45 USD | — | 582K USD | -2106,0% |
| XBIO | XENETIC BIOSCIENCES, INC. | D- | 5,6M USD | 2,39 USD | — | 3,3M USD | -75,9% |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD. | B- | 5,4M USD | 1,55 USD | — | 1,5M USD | -558,6% |
| XTLB | XTL BIOPHARMACEUTICALS LTD. | F | 5,2M USD | 2,20 USD | — | 451K USD | -1545,2% |
| PCSA | Processa Pharmaceuticals, Inc. | bez oceny | 5,1M USD | 1,84 USD | — | — | — |
| PMCB | PHARMACYTE BIOTECH, INC. | D | 4,7M USD | 0,44 USD | — | 0,00 USD | — |
| PHIO | PHIO PHARMACEUTICALS CORP. | bez oceny | 4,6M USD | 1,01 USD | — | — | — |
| DRMA | DERMATA THERAPEUTICS, INC. | bez oceny | 4,6M USD | 1,14 USD | — | — | — |
| ADXN | Addex Therapeutics Ltd | D- | 4,5M USD | 3,65 USD | — | 36K USD | -22 448,4% |
| GRI | GRI BIO, INC. | bez oceny | 4,5M USD | 2,05 USD | — | — | — |
| QNTM | Quantum BioPharma Ltd. | bez oceny | 4,4M USD | 3,85 USD | — | — | — |
| SXTP | 60 DEGREES PHARMACEUTICALS, INC. | D- | 4,1M USD | 1,17 USD | — | 1,1M USD | -729,9% |
| CVKD | Cadrenal Therapeutics, Inc. | bez oceny | 4,1M USD | 1,15 USD | — | — | — |
| OSRH | OSR HEALTH, INC. | D- | 4,1M USD | 0,12 USD | — | 1,8M USD | -824,4% |
| EVGN | EVOGENE LTD. | D- | 3,6M USD | 0,42 USD | — | 1,3M USD | -649,2% |
| HCWB | HCW Biologics Inc. | B- | 3,5M USD | 1,93 USD | — | 6,7M USD | -83,8% |
| MBIO | MUSTANG BIO, INC. | bez oceny | 3,5M USD | 0,52 USD | — | — | — |
| REVB | REVELATION BIOSCIENCES, INC. | bez oceny | 3,5M USD | 0,87 USD | — | — | — |
| HLSQ | BiomX Inc. | bez oceny | 3,4M USD | 0,53 USD | — | — | — |
| APVO | Aptevo Therapeutics Inc. | bez oceny | 3,4M USD | 1,89 USD | — | — | — |
| PBM | PSYENCE BIOMEDICAL LTD | bez oceny | 3,1M USD | 5,56 USD | — | — | — |
| AZTR | Azitra, Inc. | F- | 2,9M USD | 0,17 USD | — | 0,00 USD | — |
| SILO | SILO PHARMA, INC. | F- | 2,8M USD | 1,75 USD | — | 54,1K USD | -8269,5% |
| TCRT | Alaunos Therapeutics, Inc. | D- | 2,8M USD | 1,09 USD | — | 3K USD | -133 666,7% |
| GNPX | Genprex, Inc. | D | 2,7M USD | 3,29 USD | — | 0,00 USD | — |
| GOVX | GEOVAX LABS, INC. | D | 2,6M USD | 0,35 USD | — | 0,00 USD | — |
| VBIO | Valion Bio, Inc. | F- | 2,2M USD | 3,03 USD | — | 482K USD | -3890,0% |
| OGEN | ORAGENICS, INC. | bez oceny | 2,2M USD | 0,49 USD | — | — | — |
| AIM | AIM IMMUNOTECH INC. | D | 2,1M USD | 0,19 USD | — | 95K USD | -15 021,1% |
| JUNS | JUPITER NEUROSCIENCES, INC. | F | 2,1M USD | 2,67 USD | — | 21,8K USD | -42 206,9% |
| DCOY | Decoy Therapeutics Inc. | bez oceny | 2M USD | 3,09 USD | — | — | — |
| SPRC | SCISPARC LTD. | F- | 1,9M USD | 5,21 USD | — | 856K USD | -1422,8% |
| CANF | Can-Fite BioPharma Ltd. | F- | 1,8M USD | 2,16 USD | — | 405K USD | -2426,7% |
| LABT | Lakewood-Amedex Biotherapeutics Inc. | bez oceny | 1,8M USD | 1,67 USD | — | — | — |
| CRIS | CURIS, INC. | F- | 1,7M USD | 0,83 USD | — | 4,3M USD | -490,3% |
| RNAZ | TRANSCODE THERAPEUTICS, INC. | bez oceny | 1,6M USD | 1,69 USD | — | — | — |
| BBLG | BONE BIOLOGICS CORPORATION | bez oceny | 1,4M USD | 0,50 USD | — | — | — |
| ONCO | Onconetix, Inc. | D- | 1,2M USD | 1,03 USD | — | 645,8K USD | -1578,8% |
| VIVS | VivoSim Labs, Inc. | D | 1,2M USD | 0,22 USD | — | 112K USD | -11 016,1% |
| CLDI | Calidi Biotherapeutics, Inc. | bez oceny | 1,2M USD | 1,13 USD | — | — | — |
| QNRX | Quoin Pharmaceuticals Ltd. | bez oceny | 1,1M USD | 6,43 USD | — | — | — |
| MTNB | MATINAS BIOPHARMA HOLDINGS, INC. | bez oceny | 1M USD | 0,16 USD | — | — | — |
| CMND | Clearmind Medicine Inc. | bez oceny | 933,2K USD | 0,80 USD | — | — | — |
| PPCB | PROPANC BIOPHARMA, INC. | bez oceny | 708,3K USD | 0,63 USD | — | — | — |
| KLRA | Kailera Therapeutics, Inc. | bez oceny | 573,4K USD | 11,22 USD | — | — | — |
| PLRZ | Polyrizon Ltd. | bez oceny | 488,7K USD | 10,78 USD | 2,20 | — | — |
| EDVA | SPLASH BEVERAGE GROUP, INC. | D | 408,6K USD | 0,19 USD | — | 32,1K USD | -53 856,5% |
| BDRX | Biodexa Pharmaceuticals PLC | bez oceny | 370,9K USD | 0,68 USD | — | — | — |
| SLXN | SILEXION THERAPEUTICS CORP | bez oceny | 131,8K USD | 0,26 USD | — | — | — |
| NEUP | Neuphoria Therapeutics Inc. | F- | 109,7K USD | 3,65 USD | — | 1,2M USD | -1145,7% |
| KPTI | Karyopharm Therapeutics Inc. | B | 41,3K USD | 1,62 USD | — | 146,6M USD | -153,3% |
| CDT | CDT EQUITY INC. | bez oceny | 24,3K USD | 0,08 USD | — | — | — |
| PPBT | PURPLE BIOTECH LTD. | bez oceny | 362,44 USD | 1,51 USD | — | — | — |
| ADRX | ADARx Pharmaceuticals, Inc. | bez oceny | — | 19,35 USD | — | — | — |
| APGE | Apogee Therapeutics, Inc. | bez oceny | — | 135,07 USD | — | — | — |
| ATAI | AtaiBeckley Inc. | bez oceny | — | 7,35 USD | — | 4,1M USD | -16 142,0% |
| BRNS | BARINTHUS BIOTHERAPEUTICS PLC | D- | — | 0,74 USD | — | 0,00 USD | — |
| CRNX | Crinetics Pharmaceuticals, Inc. | D- | — | 84,95 USD | — | 42,2M USD | -1189,9% |
| ETRA | Electra Therapeutics, Inc. | bez oceny | — | 11,55 USD | — | — | — |
| FBRX | FORTE BIOSCIENCES, INC. | bez oceny | — | 76,99 USD | — | — | — |
| SLBT | SL Science Holding Limited | bez oceny | — | 1,57 USD | — | — | — |
| VCRE | Vicore Pharma Holding AB | bez oceny | — | 9,65 USD | — | — | — |
| VRXA | Veraxa Biotech Holding AG | bez oceny | — | 1,41 USD | — | — | — |
| VTVT | vTv Therapeutics Inc. | D- | — | 30,21 USD | — | 36,8M USD | -12,9% |
Fundamenty z raportów do SEC, kursy z ostatniego przebiegu danych rynkowych. Sortuj po dowolnej kolumnie; spółki bez liczby lądują na końcu w obie strony.
Posortowane według kapitalizacji, od największej; kliknij dowolną kolumnę, żeby posortować inaczej. Spółki bez liczby lądują na końcu w obie strony, bo brak C/Z oznacza stratę, a nie okazję. Nic tutaj nie jest rekomendacją.